Practical — And Crucial — Actions To Take Now For DSCSA Compliance

Two Labs Pharma Services Celebrates 20th Anniversary

Two Labs Expands Services with State Drug Price Transparency Managed Service Offerings

Avoid Launch Delays By Planning For An FDA-Required REMS

Two Labs expands product launch services with the addition of Risk Evaluation & Mitigation Strategy (REMS) offerings

Why Emerging Manufacturers Need Specialized Communications That Are Built To Scale

Effective Medical Communications During CGT Clinical Trials

As the cell and gene therapy market has exponentially grown in recent years — with some reports predicting it will reach $24.4 billion with 54 to 74 approvals by 2030 — many manufacturers are learning the hard way just how … ...
Achieving Launch Excellence in Oncology

It’s no surprise that putting together a successful launch strategy for an oncology product is a complex process. And we’ve heard from many of our emerging pharma clients that it’s intimidating to see how saturated and competitive the landscape is.… ...
Two Labs Adds Medical Affairs & Communications to Suite of Services

In a market where most medical affairs and medical communications service providers are built to support large pharma, Two Labs is aiming to fill the gap for small and emerging biopharma and biotech manufacturers with the launch of Medical Affairs … ...
Adding State Licensing to Your Cell and Gene Launch Strategy

The main question that sits at the center of the most common licensing questions and obstacles for cell and gene strategies: how do companies license a product that is often never touched by the parties that need to hold the … ...